Skinvisible, Inc.’s (OTCQB: SKVI) proprietary topical drug delivery technology, Invisicare®, improves the delivery of pharmaceutical and medicinal compounds to and through the skin. The company develops hemp-based products and recently expanded its product line to the enter the cannabis-based topical product market. An article discussing this reads: “The patented polymer technology has been used in … Continue reading “CBDNewsBreaks – Skinvisible, Inc. (SKVI) Develops Hemp-based Products with an Enhanced Delivery System”
Skinvisible already develops hemp-based products and is expanding its product line of cannabis-based topical product market Research verifies its Invisicare® technology improves the penetration rate and boosts the availability of the cannabis ingredients in both topical and transdermal products Skinvisible has entered a strategic partnership with Canopy Growth Corporation for the sale of its product … Continue reading “Skinvisible, Inc.’s (SKVI) Patented Polymer Delivery Technology Could Take CBD Products to the Next Level”
Research and development company Skinvisible, Inc. (OTCQB: SKVI) has developed Invisicare® technology, a patented polymer delivery system that improves the delivery of topically applied skin care products by enhancing the effectiveness of the active ingredients. Skinvisible out-licenses its formulations, enabling companies like Canopy Hemp Corporation to bring their own patented products to market and combat … Continue reading “CBDNewsBreaks – Skinvisible, Inc.’s (SKVI) Invisicare Technology Tackles Dermatology, CBD Markets”
Owns patented Invisicare® polymer delivery system, prescription and over-the-counter skincare products formulated with Invisicare Business model to grow globally by out-licensing its proprietary and patented product line Developed multiple cannabis-based products with CBD from imported hemp (non-psychoactive), and will continue to develop line utilizing CBD and THC from marijuana Skinvisible, Inc. (OTCQB: SKVI) is targeting … Continue reading “Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021”
Topical product technology protected by patents Targeting $80 billion global skin care and dermatology market Product sales in China Outsourcing has been the status quo in the pharmaceutical industry since long before the term gained notoriety. Large pharmaceutical and cosmeceutical companies, under pressure from rising R&D costs, have been farming out that part of their … Continue reading “Skinvisible, Inc. (SKVI) Has Been Delivering its Patented Polymer Technology to Pharmaceuticals & Cosmeceuticals for Close to Two Decades”
Patented technology enhances how topical and transdermal drugs and skin care products are delivered Polymer delivery vehicle can be tailored to almost any type of molecule including the medicinal components of hemp and marijuana 14 patents granted in the U.S. and internationally $65 billion market in dermatology, pharmaceutical and other healthcare industries offers strong growth … Continue reading “Skinvisible, Inc. (SKVI) is “One to Watch””
NetworkNewsWire Coverage: Medical cannabis use has been legal in Canada since 2001, and Canada is now working to become the first industrialized nation to input a comprehensive system permitting the recreational use of marijuana. Sweeping legislation has been introduced by the Canadian government that takes aim at permitting nationwide recreational cannabis use by July 2018—a … Continue reading “As Recreational Cannabis Legalization Looms, the Field of Opportunity is Green for Canada’s Leading Growers”
NetworkNewsWire Coverage: Growing marijuana in North America, for obvious reasons, has historically been an underground affair. Amid growing legalization in favor of recreational and medicinal use, growing cannabis on mass scale is rapidly becoming a necessity for companies in a burgeoning industry driven by incredible consumer demand. Canada is ahead of the United States in … Continue reading “Canadian Cannabis Leaders Sharpen Focus on Increasing Yield, Plant Quality”
NetworkNewsWire Editorial Coverage: Canada is the mecca of the North American cannabis market, boasting legalization in every province and an array of investment opportunities, such as ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF), a Canadian grower of medical marijuana. ABcann recently acquired ABcann Medicinals and boasts a recent IPO, appointment of a new medical consultant, … Continue reading “Investors Eye Sweet Spots in Canada’s Booming Cannabis Market”
Now that shares of ABcann Global Corporation (TSXV: ABCN) are trading on the venture arm of the Toronto Stock Exchange (TSX), the company is creating more buzz than ever. On the same day it launched its initial public offering (IPO) (May 4), industry analysts PI Financial initiated coverage of the stock with a decidedly bullish … Continue reading “ABcann Global (TSXV: ABCN) Target Price Set At $2.25 as Coverage is Initiated”
